Severe contact urticaria, mimicking allergic contact dermatitis, due to a surgical mask worn during the COVID-19 pandemic

Allergic Diseases

Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status

Allergy.

Du H, Dong X, Zhang JJ, Cao YY, Akdis M, Huang PQ, Chen HW, Li Y, Liu GH, Akdis CA, Lu XX, Gao YD

doi: 10.1111/all.14452.

Allergic Diseases

Considerations on Biologicals for Patients with allergic disease in times of the COVID-19 pandemic: an EAACI Statement

Allergy.

Vultaggio A, Agache I, Akdis CA, Akdis M, Bavbek S, Bossios A, Bousquet J, Boyman O, Chaker AM, Chan S, Chatzipetrou A, Feleszko W, Firinu D, Jutel M, Kauppi P, Klimek L, Kolios A, Kothari A, Kowalski ML, Matucci A, Palomares O, Pfaar O, Rogala B, Untersmayr E, Eiwegger T

doi: 10.1111/all.14407.

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Capturing patient-reported outcomes during the COVID-19 pandemic: Development of the COVID-19 Global Rheumatology Alliance Patient Experience Survey

Arthritis Care Res (Hoboken).

Sirotich E, Dillingham S, Grainger R, Hausmann JS, COVID-19 Global Rheumatology Alliance Steering Committee.

doi: 10.1002/acr.24257.

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

European Task Force on Contact Dermatitis statement on coronavirus 19 disease (COVID-19) outbreak and the risk of adverse cutaneous reactions

J Eur Acad Dermatol Venereol.

Balato A, Ayala F, Bruze M, Crepy MN, Gonçalo M, Duus Johansen J, John SM, Pigatto P, Raimondo A, Rustemeyer T, Schuttelaar MA, Svedman C, Aerst O, Uter W, Wilkinson M, Gimenez-Arnau A

doi: 10.1111/jdv.16557.

Atopic DermatitisPsoriasis

Global reporting of cases of COVID-19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic

Br J Dermatol.

Mahil SK, Yiu ZZN, Mason KJ, Dand N, Coker B, Wall D, Fletcher G, Bosma A, Capon F, Iversen L, Langan SM, Di Meglio P, Musters A, Prieto-Merino D, Tsakok T, Warren RB, Flohr C, Spuls P, Griffiths CEM, Barker J, Irvine AD, Smith CH, Secure-AD, PsoPROTECT study groups.

doi: 10.1111/bjd.19161.

Psoriasis

National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 2 - Advances in Psoriatic Disease Management, COVID-19 Vaccines, and COVID-19 Treatments

J Am Acad Dermatol

Gelfand JM, Armstrong AW, Bell S, Anesi GL, Blauvelt A, Calabrese C, Dommasch ED, Feldman SR, Gladman D, Kircik L, Lebwohl M, Lo Re V 3rd, Martin G, Merola JF, Scher JU, Schwartzman S, Treat JR, Van Voorhees AS, Ellebrecht CT, Fenner J, Ocon A, Syed MN, Weinstein EJ, Gondo G, Heydon S, Koons S, Ritchlin CT

doi: 10.1016/j.jaad.2020.12.058

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Elevated plasma sTIM-3 levels in severe Covid-19 patients

J Allergy Clin Immunol.

Ueland T, Heggelund L, Lind A, Holten AR, Tonby K, Michelsen AE, Jenum S, Jørgensen MJ, Barratt-Due A, Skeie LG, Nordøy I, Aanensen Fraz MS, Quist-Paulsen E E, Pischke SE, Johal SK, Hesstvedt L, Bogen M, Fevang B, Halvorsen B, Müller F, Bekken GK, Mollnes TE, Dudman S, Aukrust P, Dyrhol-Riise AM, Holter JC

doi: 10.1016/j.jaci.2020.09.007.

Allergic DiseasesImmunodeficiency

Managing childhood allergies and immunodeficiencies during respiratory virus epidemics - the 2020 COVID-19 pandemic

Pediatr Allergy Immunol.

Brough HA, Kalayci O, Sediva A, Untersmayr E, Munblit D, Rodriquez Del Rio P, Vazquez-Ortiz M, Arasi S, Alvaro-Lozano M, Tsabouri S, Galli E, Beken B, Eigenmann PA

doi: 10.1111/pai.13262.

Further Publications Rheumatology

Medication access difficulty and COVID-related distress are associated with disease flares in rheumatology patients during the COVID-19 pandemic

Arthritis Care Res (Hoboken)

Maldonado D, Tu E, Mahmood S, Wahezi D, Darapaneni R, Sima N, Curiel-Duran L, Pattison LM, Gabbay V, Bauman LJ, Broder A, Rubinstein TB

doi: 10.1002/acr.24531

Related content

Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status

Considerations on Biologicals for Patients with allergic disease in times of the COVID-19 pandemic: an EAACI Statement

Capturing patient-reported outcomes during the COVID-19 pandemic: Development of the COVID-19 Global Rheumatology Alliance Patient Experience Survey

European Task Force on Contact Dermatitis statement on coronavirus 19 disease (COVID-19) outbreak and the risk of adverse cutaneous reactions

Global reporting of cases of COVID-19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic

National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 2 - Advances in Psoriatic Disease Management, COVID-19 Vaccines, and COVID-19 Treatments

Elevated plasma sTIM-3 levels in severe Covid-19 patients

Managing childhood allergies and immunodeficiencies during respiratory virus epidemics - the 2020 COVID-19 pandemic

Medication access difficulty and COVID-related distress are associated with disease flares in rheumatology patients during the COVID-19 pandemic